Stock listing
Cytokinetics, Incorporated
- Ticker
- NASDAQ:CYTK
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Cytokinetics, Incorporated
The company focuses on developing innovative treatments for serious diseases, particularly in the fields of muscle biology and neuromuscular disorders. Cytokinetics is committed to advancing its research and product pipeline to improve patient outcomes.
Latest news from Cytokinetics, Incorporated
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
Oct 2, 2026
Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Sep 30, 2026
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
Sep 14, 2026
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
Aug 29, 2026